PE20151208A1 - Composiciones de diclofenaco - Google Patents
Composiciones de diclofenacoInfo
- Publication number
- PE20151208A1 PE20151208A1 PE2015001194A PE2015001194A PE20151208A1 PE 20151208 A1 PE20151208 A1 PE 20151208A1 PE 2015001194 A PE2015001194 A PE 2015001194A PE 2015001194 A PE2015001194 A PE 2015001194A PE 20151208 A1 PE20151208 A1 PE 20151208A1
- Authority
- PE
- Peru
- Prior art keywords
- diclofenac
- composition
- present
- compositions
- diclofenaco
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion se refiere una composicion que comprende diclofenaco y sales del mismo, donde el diclofenaco o su sal estan presentes en una cantidad de 25 a 200 mg. La composicion es adecuada para la administracion parenteral a traves de la via intramuscular e intravenosa; tambien por via oral, dermica, subcutanea, cutanea, nasal, gotas oculares, como supositorio rectal, pesarios vaginales, intra-articular, liberacion otica. La invencion tambien proporciona composiciones que comprenden una combinacion de diclofenaco y otros farmacos. La invencion proporciona ademas un metodo para preparar dicha composicion
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3704MU2012 | 2012-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20151208A1 true PE20151208A1 (es) | 2015-08-23 |
Family
ID=54198802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2015001194A PE20151208A1 (es) | 2012-12-28 | 2013-12-27 | Composiciones de diclofenaco |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20140187635A1 (es) |
| EP (1) | EP2938325B8 (es) |
| JP (1) | JP6117939B2 (es) |
| KR (1) | KR101730284B1 (es) |
| CN (1) | CN104968331A (es) |
| AP (1) | AP2015008534A0 (es) |
| AU (1) | AU2013368849B2 (es) |
| BR (1) | BR112015015699B1 (es) |
| CL (1) | CL2015001869A1 (es) |
| EA (1) | EA035079B1 (es) |
| ES (1) | ES2721400T3 (es) |
| HK (1) | HK1211858A1 (es) |
| HU (1) | HUE045030T2 (es) |
| IL (1) | IL239395A0 (es) |
| MA (1) | MA38292A1 (es) |
| MX (1) | MX365375B (es) |
| MY (1) | MY184886A (es) |
| PE (1) | PE20151208A1 (es) |
| PH (1) | PH12015501479A1 (es) |
| SG (1) | SG11201504577UA (es) |
| SI (1) | SI2938325T1 (es) |
| TR (1) | TR201905806T4 (es) |
| UA (1) | UA114123C2 (es) |
| WO (1) | WO2014102824A1 (es) |
| ZA (1) | ZA201504258B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101524473B1 (ko) * | 2014-12-22 | 2015-06-02 | 주식회사 한국팜비오 | 주사제 조성물 |
| WO2016170401A1 (en) * | 2015-04-20 | 2016-10-27 | Umedica Laboratories Pvt. Ltd | Novel injectable composition of diclofenac sodium |
| US11110073B2 (en) | 2017-03-24 | 2021-09-07 | Cadila Healthcare Limited | Storage stable aqueous injectable solution comprising diclofenac |
| GB201720992D0 (en) * | 2017-12-15 | 2018-01-31 | Hooper Mark | A medical use |
| GR1009729B (el) * | 2018-08-02 | 2020-05-15 | Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια | Σταθερος ενεσιμος συνδυασμος |
| US11744899B2 (en) * | 2018-11-16 | 2023-09-05 | Seikagaku Corporation | Pharmaceutical composition containing a hyaluronic acid derivative |
| US20220280463A1 (en) | 2019-09-09 | 2022-09-08 | Ftf Pharma Private Limited | Pharmaceutical formulations comprising diclofenac |
| US11707443B2 (en) | 2019-09-26 | 2023-07-25 | Rk Pharma Inc. | Storage stable aqueous parenteral solutions comprising diclofenac |
| EP4106724A1 (en) * | 2020-02-18 | 2022-12-28 | Novo Nordisk A/S | Glp-1 compositions and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3324193A1 (de) | 1983-07-05 | 1985-01-17 | Troponwerke Gmbh & Co Kg | Depot-antiphlogistika |
| DE3446873A1 (de) | 1984-12-21 | 1986-07-10 | Merckle Gmbh | Fluessige diclofenac-zubereitungen |
| US5283067A (en) * | 1987-01-30 | 1994-02-01 | Ciba-Geigy Corporation | Parenteral suspensions |
| EP0661050A1 (en) * | 1991-07-04 | 1995-07-05 | Taisho Pharmaceutical Co. Ltd | Analgesic |
| US5389681A (en) | 1992-10-22 | 1995-02-14 | Ciba-Geigy Corporation | Parenteral solutions for diclofenac salts |
| ZA949182B (en) | 1993-12-02 | 1995-07-26 | South African Druggists Ltd | Pharmaceutical composition |
| JP4542743B2 (ja) * | 2002-12-26 | 2010-09-15 | Ｋｄｌ株式会社 | ピリドン誘導体の溶液状医薬組成物 |
| AU2004226323A1 (en) * | 2003-03-26 | 2004-10-14 | Becton, Dickinson And Company | Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection |
| US20050137164A1 (en) | 2003-09-22 | 2005-06-23 | Moshe Arkin | Diclofenac compositions for the treatment of skin disorders |
| DK1767219T3 (da) | 2004-03-10 | 2010-05-10 | Shimoda Biotech Pty Ltd | Stabile injicerbare diclofenac-sammensætninger |
| US20050214230A1 (en) * | 2004-03-23 | 2005-09-29 | J. B. Chemicals & Pharmaceuticals Ltd. | Novel stomatological gel |
| AP2888A (en) * | 2005-02-01 | 2014-05-31 | Troikaa Pharmaceuticals Ltd | Injectable preparations of diclofenic and its pharmaceutically acceptable salts |
| MX2007014862A (es) * | 2005-05-27 | 2008-02-21 | Panacea Biotec Ltd | Composiciones inyectables y procedimiento para la preparacion de dichas composiciones. |
| EP2364140A1 (en) | 2008-11-28 | 2011-09-14 | Advance Holdings Limited | Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester |
-
2013
- 2013-12-24 US US14/140,109 patent/US20140187635A1/en not_active Abandoned
- 2013-12-27 WO PCT/IN2013/000805 patent/WO2014102824A1/en active Application Filing
- 2013-12-27 MX MX2015008369A patent/MX365375B/es active IP Right Grant
- 2013-12-27 MY MYPI2015001527A patent/MY184886A/en unknown
- 2013-12-27 JP JP2015550212A patent/JP6117939B2/ja active Active
- 2013-12-27 SI SI201331424T patent/SI2938325T1/sl unknown
- 2013-12-27 ES ES13830158T patent/ES2721400T3/es active Active
- 2013-12-27 CN CN201380068194.2A patent/CN104968331A/zh active Pending
- 2013-12-27 PE PE2015001194A patent/PE20151208A1/es not_active Application Discontinuation
- 2013-12-27 KR KR1020157017781A patent/KR101730284B1/ko active IP Right Grant
- 2013-12-27 UA UAA201506371A patent/UA114123C2/uk unknown
- 2013-12-27 EP EP13830158.5A patent/EP2938325B8/en active Active
- 2013-12-27 TR TR2019/05806T patent/TR201905806T4/tr unknown
- 2013-12-27 MA MA38292A patent/MA38292A1/fr unknown
- 2013-12-27 HU HUE13830158A patent/HUE045030T2/hu unknown
- 2013-12-27 AU AU2013368849A patent/AU2013368849B2/en active Active
- 2013-12-27 EA EA201591230A patent/EA035079B1/ru not_active IP Right Cessation
- 2013-12-27 AP AP2015008534A patent/AP2015008534A0/xx unknown
- 2013-12-27 BR BR112015015699-1A patent/BR112015015699B1/pt active IP Right Grant
- 2013-12-27 SG SG11201504577UA patent/SG11201504577UA/en unknown
-
2015
- 2015-06-11 ZA ZA2015/04258A patent/ZA201504258B/en unknown
- 2015-06-14 IL IL239395A patent/IL239395A0/en unknown
- 2015-06-26 CL CL2015001869A patent/CL2015001869A1/es unknown
- 2015-06-26 PH PH12015501479A patent/PH12015501479A1/en unknown
- 2015-12-30 HK HK15112837.5A patent/HK1211858A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20151208A1 (es) | Composiciones de diclofenaco | |
| CR20160140A (es) | Derivados de quinolizina sustituidos útiles como inhibidores de integrasa del vih | |
| MX2020008468A (es) | Mejoramiento de autofagia o incremento de longevidad por administracion de urolitinas o precursores de las mismas. | |
| EA201890942A1 (ru) | Мультивалентные вакцины с синтетическими наноносителями | |
| BR112014032990A2 (pt) | seringa | |
| AR092317A1 (es) | Vectores virales para el tratamiento de distrofia retiniana | |
| AR091837A1 (es) | Compuestos para inmunoterapia dirigida | |
| UA113165C2 (xx) | Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат | |
| BR112012033755A2 (pt) | composições e métodos antissépticos estáveis | |
| ECSP15012804A (es) | Alcoxipirazoles como activadores de guanilato ciclasa soluble | |
| CO6251282A2 (es) | Oxazolidinonas sustituidas y su uso | |
| AR093126A1 (es) | Formulaciones de liberacion modificada para oprozomib | |
| BR112015003957A2 (pt) | alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria | |
| BR112014010376A2 (pt) | medicamento para o tratamento de doença do olho anterior que compreende rebamipida e um agente de retenção de lágrima | |
| BR112013029149A2 (pt) | processo de produção de material inorgânico em partículas | |
| BR112015030431A2 (pt) | formulação de liberação modificada | |
| ECSP14013155A (es) | 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia | |
| BR112014018738A8 (pt) | Métodos e intermediários para preparo de agentes farmacêuticos | |
| BR112013005224A2 (pt) | "agonistas de adenosina a1 para o tratamento de glaucoma e hipertensão ocular". | |
| BR112013002230A2 (pt) | marcadores de peso molecular de acetato de glatiramer | |
| ECSP13012548A (es) | Inhibidores de oxadiazol de la producción de leucotrienos. | |
| BR112014003096A2 (pt) | uso de ccne2 como marcador de estratificação no tratamento de tumores de mama com inibidores de pan-cdk | |
| AR099328A1 (es) | Conjugados de factor vii | |
| BR112014030992A2 (pt) | composições compreendendo calcogenetos e métodos relacionados | |
| CY1116477T1 (el) | Μεθοδος εnzυμatiκης συνθεσης toy (7s)-3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριενo-7-καρβοξυλικου οξεος ή εστερων αυτου και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |